Update in neurocysticercosis treatment;Actualización en el tratamiento de la neurocisticercosis

Revista de Neurologia

Volumn 36, Issue 9, 2003, Pages 805-811

  Pérez López, Carlos ^a   Isla Guerrero, A ^a   Alvarez, F ^a   Budke, M ^a   Fernandez Miranda J C ^a   Paz, J F ^a   Perez Alvarez M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Albendazol; Inmunoblot; Neurocysticercosis; Seizures

Indexed keywords

ALBENDAZOLE; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; PHENYTOIN; PRAZIQUANTEL; ANTHELMINTIC AGENT; PARASITE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMAN; INCIDENCE; MALE; MIGRATION; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOSIS; SOUTH AMERICA; ACUTE DISEASE; ADOLESCENT; ANIMAL; BRAIN; CEREBROSPINAL FLUID; ECHINOCOCCUS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARASITOLOGY; PATHOLOGY; RADIOGRAPHY;

ACUTE DISEASE; ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; BRAIN; ECHINOCOCCUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROCYSTICERCOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038650686     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3609.2003033     Document Type: Article

References (29)

1. Greenberg MS. Handbook of neurosurgery. 5 ed. New York: Thieme; 2001. p. 236-9.
2. Sotelo J, Del Brutto OH. Review of neurocysticercosis. Neurosurg Focus 2002; 12: 1.
3. García-Albea E. Cisticercosis en España. Algunos datos epidemiológicos. Rev Clin Esp 1989; 184: 3-6.
4. Giménez-Roldán S, Chinchilla N, De Andrés C, Gil-Núñez A. Neurocisticercosis entre inmigrantes hispanoamericanos. Rev Clin Esp 1990; 186: 197.
5. Font-Puig C, Ruiz-Postigo JA, Muñoz-Batet C, Pardós-Arnal F, Corachán-Cuyás M. Neurocisticercosis en España. A propósito de cuatro casos observados en pacientes inmigrados de países endémicos. An Med Interna 1999; 16: 89-91.
6. Terraza S, Pujol T, Gascón J, Corachán M. Neurocisticercosis: ¿una enfermedad importada? Med Clin (Barc) 2001; 116: 261-3.
7. Del Brutto OH. Neurocisticercosis. Rev Neurol 1999; 29: 456-66.
8. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis and management. Ann Rev Med 2000; 51: 187-206.
9. Madrazo I, Garcia-Rentería JA, Sandoval M, Löpez-Vega FJ. Intraventricular cisticercosis. Neurosurgery 1983; 12: 148-51.
10. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 1985; 145: 442-5.
11. DeGiorgio CM, Medina MT. Introduction to neurocysticercosis: a worldwide epidemic. Neurosurg Focus 2002; 6: 12.
12. Del Brutto OH, Santibáñez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42: 389-92.
13. Carpio A, Escobar A, Hauser A W. Cysticercosis and epilepsy: a critical review. Epilepsia 1998; 39: 1025-40.
14. Del Brutto OH, Zenteno MA, Salgada P, Sotelo L. MR imaging in 14 cysticercotic encephalitis. Am J Neuroradiol 1989; 10: 18-20.
15. Rangel R, Torres B, Del Brutto O, Sotelo J. Cysticercosis encephalitis: A severe form in young females. Am J Trop Med Hyg 1987; 36: 387.
16. Lobato RD, Lamas E, Portillo JM, Roger J, Esparza J, Rivas JJ, et al. Hydrocephalus in cerebral cisticercosis. Pathogenic and therapeutic considerations. J Neurosurg 1981; 55: 786-93.
17. Kramer J, Carrazana E, Cosgrove GR, Kleefield J, Edelman RR. Transaqueductal migration of a neurocysticercus cyst. J Neurosurg 1992; 163: 956-8.
18. Ginier BL, Poirier V. MR imaging of intraventricular cysticercosis. Am J Neuroradiol 1992; 13: 1247-8
19. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57: 177-83.
20. Schantz P, Sarti E, Plancarte A, Wilson M, Roberts J, Flisser A. Clinical, radiological and epidemiological correlations of ELISA and inmunoblot assays for Taenia solium cysticercosis in two populations in México. Am J Trop Med Hyg 1991; 45 (Suppl): 130-1.
21. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapewom infection of the brain). The Cochrane Library. Cochrane Database Syst Rev 2000; 2: CD 000215.
22. Carpio A, Santillán F, León P, Flores C, Hauser A. Is the course of neurocysticercosis modified by treatment with antihelmintic agents? Arch Intern Med 1995; 155: 1982-8.
23. Vásquez N, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992; 327: 696-701.
24. Colli BO, Carlotti CG, Assirati JA, Machado HR, Valença M, Amato MCM, et al. Surgical treatment of cerebral cysticercosis: long-term results and prognostic factors. Neurosurg Focus 2002; 12: 3.
25. Antoniuk S. Epidemiología de la neurocisticercosis. Rev Neurol 1999; 29: 331-4.
26. Schantz P, Moore A, Muñoz J, Hartman B, Shaefer J, Aron A, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992; 327: 692-5.
27. Cruz M, Davis A, Dixon H, Pawlowski Z, Poraño J. Operational studies on the control of taeniasis/cisticercosis in Ecuador. Bull WHO 1989; 67: 401-7.
28. Pawlowski Z. Efficacy of low doses of praziquantel in teniasis. Acta Trop 1991; 48: 83-8.
29. Díaz-Camacho SP, Candil-Ruíz A, Suate-Peraza V, Zazueta-Ramos ML, Félix-Medina M, Lozano R, et al. Epidemiologic study and control of Taenia solium infections with paziquantel in a rural village of Mexico. Am J Trop Med Hyg 1991; 45: 522-31.